News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Emerald BioStructures Leads International Consortium to Crystallize Key Parkinson's Disease Enzyme


12/9/2010 8:52:46 AM

BAINBRIDGE ISLAND, Wash.--(BUSINESS WIRE)--Emerald BioStructures, a leading provider of integrated structural biology services, has received funding from The Michael J. Fox Foundation for Parkinson’s Research to lead a consortium working to crystallize and solve the structure of the enzyme believed to be a key molecular mechanism behind Parkinson’s disease.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES